Literature DB >> 23494862

A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release.

Jin-Oh You1, Peng Guo, Debra T Auguste.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23494862      PMCID： PMC5540660          DOI： 10.1002/anie.201209804

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  37 in total

1.  A molecularly targeted theranostic probe for ovarian cancer.

Authors:  Wenxue Chen; Rizia Bardhan; Marc Bartels; Carlos Perez-Torres; Robia G Pautler; Naomi J Halas; Amit Joshi
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

2.  Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics.

Authors:  Chia-Hung Lee; Shih-Hsun Cheng; I-Ping Huang; Jeffrey S Souris; Chung-Shi Yang; Chung-Yuan Mou; Leu-Wei Lo
Journal:  Angew Chem Int Ed Engl       Date:  2010-10-25       Impact factor: 15.336

3.  Immunotargeted nanoshells for integrated cancer imaging and therapy.

Authors:  Christopher Loo; Amanda Lowery; Naomi Halas; Jennifer West; Rebekah Drezek
Journal:  Nano Lett       Date:  2005-04       Impact factor: 11.189

4.  Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells.

Authors:  Alessandro Ottaiano; Antonella di Palma; Maria Napolitano; Carmen Pisano; Sandro Pignata; Fabiana Tatangelo; Gerardo Botti; Angela Maria Acquaviva; Giuseppe Castello; Paolo Antonio Ascierto; Rosario Vincenzo Iaffaioli; Stefania Scala
Journal:  Cancer Immunol Immunother       Date:  2004-12-11       Impact factor: 6.968

5.  Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery.

Authors:  Ji-Ho Park; Geoffrey von Maltzahn; Luvena L Ong; Andrea Centrone; T Alan Hatton; Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  Adv Mater       Date:  2010-02-23       Impact factor: 30.849

Review 6.  Micellar nanocarriers: pharmaceutical perspectives.

Authors:  V P Torchilin
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.200

7.  Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity.

Authors:  Peng Guo; Jin-Oh You; Jiang Yang; Marsha A Moses; Debra T Auguste
Journal:  Biomaterials       Date:  2012-08-09       Impact factor: 12.479

8.  Depth of penetration of an 850nm wavelength low level laser in human skin.

Authors:  Alan Esnouf; Philip A Wright; Joan C Moore; Salim Ahmed
Journal:  Acupunct Electrother Res       Date:  2007       Impact factor: 0.143

9.  Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.

Authors:  J Baselga; L Norton; J Albanell; Y M Kim; J Mendelsohn
Journal:  Cancer Res       Date:  1998-07-01       Impact factor: 12.701

Review 10.  Update on HER-2 as a target for cancer therapy: herceptin in the clinical setting.

Authors:  D W Miles
Journal:  Breast Cancer Res       Date:  2001-10-11       Impact factor: 6.466
View more
  5 in total

1.  Periodic Mesoporous Organosilica Coated Prussian Blue for MR/PA Dual-Modal Imaging-Guided Photothermal-Chemotherapy of Triple Negative Breast Cancer.

Authors:  Wei Tian; Yunyan Su; Ying Tian; Shouju Wang; Xiaodan Su; Ying Liu; Yunlei Zhang; Yuxia Tang; Qianqian Ni; Wenfei Liu; Meng Dang; Chunyan Wang; Junjie Zhang; Zhaogang Teng; Guangming Lu
Journal:  Adv Sci (Weinh)       Date:  2016-11-21       Impact factor: 16.806

2.  Incorporating gold nanoclusters and target-directed liposomes as a synergistic amplified colorimetric sensor for HER2-positive breast cancer cell detection.

Authors:  Yu Tao; Mingqiang Li; Bumjun Kim; Debra T Auguste
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

3.  Utilization of H-bond interaction of nucleobase Uralic with antitumor methotrexate to design drug carrier with ultrahigh loading efficiency and pH-responsive drug release.

Authors:  Teng-Teng Cai; Qi Lei; Bin Yang; Hui-Zhen Jia; Hong Cheng; Li-Han Liu; Xuan Zeng; Jun Feng; Ren-Xi Zhuo; Xian-Zheng Zhang
Journal:  Regen Biomater       Date:  2014-10-20

4.  Mesoporous silica nanoparticle-based intelligent drug delivery system for bienzyme-responsive tumour targeting and controlled release.

Authors:  Yang Zhang; Juan Xu
Journal:  R Soc Open Sci       Date:  2018-01-10       Impact factor: 2.963

5.  Development of dihydrochalcone-functionalized gold nanoparticles for augmented antineoplastic activity.

Authors:  Jason N Payne; Vivek D Badwaik; Hitesh K Waghwani; Harsh V Moolani; Sarah Tockstein; David H Thompson; Rajalingam Dakshinamurthy
Journal:  Int J Nanomedicine       Date:  2018-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.